Extracellular vesicle-mediated suicide mRNA/protein delivery inhibits glioblastoma tumor growth in vivo

Cancer Gene Therapy

Volumn 24, Issue 1, 2017, Pages 38-44

  Erkan, E P ^a,c   Senfter, D ^a   Madlener, S ^a   Jungwirth, G ^b   Strobel T ^a   Saydam, N ^a   Saydam, O ^a  

^a UNIV KLIN KINDER JUGENDHEILKUNDE   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE DEAMINASE; FLUCYTOSINE; URACIL PHOSPHORIBOSYLTRANSFERASE; GLYCOSYLTRANSFERASE; MESSENGER RNA; PRODRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GENE THERAPY; CANCER INHIBITION; CELL ISOLATION; CONTROLLED STUDY; DNA REPLICATION; E98 CELL LINE; EXOSOME; GENETIC ENGINEERING; GLIOBLASTOMA; GLIOBLASTOMA CELL LINE; HEK293 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NONVIRAL GENE THERAPY; PRIORITY JOURNAL; SUICIDE GENE; SUICIDE GENE THERAPY; TUMOR GROWTH; TUMOR MODEL; TUMOR SPHEROID; TUMOR XENOGRAFT; U251 MG CELL LINE; U87 MG CELL LINE; ANIMAL; CELL CYCLE; CELL SURVIVAL; DISEASE MODEL; DRUG DELIVERY SYSTEM; DRUG EFFECTS; DRUG SCREENING; FEMALE; GENE EXPRESSION; GENE TRANSFER; GENETICS; METABOLISM; PATHOLOGY; SCID MOUSE; SUICIDE TRANSGENE; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL CULTURE; TUMOR CELL LINE; TUMOR VOLUME;

ANIMALS; APOPTOSIS; BIOLOGICAL TRANSPORT; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; EXTRACELLULAR VESICLES; FEMALE; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENES, TRANSGENIC, SUICIDE; GENETIC ENGINEERING; GLIOBLASTOMA; HUMANS; MICE; MICE, SCID; PENTOSYLTRANSFERASES; PRODRUGS; RNA, MESSENGER; TUMOR BURDEN; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 85006295096     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/cgt.2016.78     Document Type: Article

References (23)

1. Bianco F, Pravettoni E, Colombo A, Schenk U, Moller T, Matteoli M et al. Astrocytederived ATP induces vesicle shedding and IL-1 beta release from microglia. J Immunol 2005; 174: 7268-7277.
2. Pizzirani C, Ferrari D, Chiozzi P, Adinolfi E, Sandona D, Savaglio E et al. Stimulation of P2 receptors causes release of IL-1beta-loaded microvesicles from human dendritic cells. Blood 2007; 109: 3856-3864.
3. Pilzer D, Fishelson Z. Mortalin/GRP75 promotes release of membrane vesicles from immune attacked cells and protection from complement-mediated lysis. Int Immunol 2005; 17: 1239-1248.
4. Balaj L, Lessard R, Dai L, Cho YJ, Pomeroy SL, Breakefield XO et al. Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat Commun 2011; 2: 180.
5. Noerholm M, Balaj L, Limperg T, Salehi A, Zhu LD, Hochberg FH et al. RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls. BMC Cancer 2012; 12: 22.
6. Waldenstrom A, Genneback N, Hellman U, Ronquist G. Cardiomyocyte microvesicles contain DNA/RNA and convey biological messages to target cells. PLoS One 2012; 7: e34653.
7. Ohno S, Takanashi M, Sudo K, Ueda S, Ishikawa A, Matsuyama N et al. Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol Ther 2013; 21: 185-191.
8. Ridder K, Keller S, Dams M, Rupp AK, Schlaudraff J, Del Turco D et al. Extracellular vesicle-mediated transfer of genetic information between the hematopoietic system and the brain in response to inflammation. PLoS Biol 2014; 12: e1001874.
9. Fleury A, Martinez MC, Le Lay S. Extracellular vesicles as therapeutic tools in cardiovascular diseases. Front Immunol 2014; 5: 370.
10. Omuro A, DeAngelis LM. Glioblastoma and other malignant gliomas: A clinical review. JAMA 2013; 310: 1842-1850.
11. Cloughesy TF, Cavenee WK, Mischel PS. Glioblastoma: from molecular pathology to targeted treatment. Annu Rev Pathol 2014; 9: 1-25.
12. Huber BE, Austin EA, Richards CA, Davis ST, Good SS. Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Proc Natl Acad Sci USA 1994; 91: 8302-8306.
13. Boucher PD, Im MM, Freytag SO, Shewach DS. A novel mechanism of synergistic cytotoxicity with 5-fluorocytosine and ganciclovir in double suicide gene therapy. Cancer Res 2006; 66: 3230-3237.
14. Mizrak A, Bolukbasi MF, Ozdener GB, Brenner GJ, Madlener S, Erkan EP et al. Genetically engineered microvesicles carrying suicide mRNA/protein inhibit schwannoma tumor growth. Mol Ther 2013; 21: 101-108.
15. Bolukbasi MF, Mizrak A, Ozdener GB, Madlener S, Strobel T, Erkan EP et al. miR-1289 and 'Zipcode'-like sequence enrich mRNAs in microvesicles. Mol Ther Nucleic Acids 2012; 1: e10.
16. Ho WY, Yeap SK, Ho CL, Rahim RA, Alitheen NB. Development of multicellular tumor spheroid (MCTS) culture from breast cancer cell and a high throughput screening method using the MTT assay. PLoS One 2012; 7: e44640.
17. Erbs P, Regulier E, Kintz J, Leroy P, Poitevin Y, Exinger F et al. In vivo cancer gene therapy by adenovirus-mediated transfer of a bifunctional yeast cytosine deaminase/uracil phosphoribosyltransferase fusion gene. Cancer Res 2000; 60: 3813-3822.
18. Kaliberov SA, Chiz S, Kaliberova LN, Krendelchtchikova V, Della Manna D, Zhou T et al. Combination of cytosine deaminase suicide gene expression with DR5 antibody treatment increases cancer cell cytotoxicity. Cancer Gene Ther 2006; 13: 203-214.
19. Adachi Y, Tamiya T, Ichikawa T, Terada K, Ono Y, Matsumoto K et al. Experimental gene therapy for brain tumors using adenovirus-mediated transfer of cytosine deaminase gene and uracil phosphoribosyltransferase gene with 5-fluorocytosine. Hum Gene Ther 2000; 11: 77-89.
20. Chung-Faye GA, Chen MJ, Green NK, Burton A, Anderson D, Mautner V et al. In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase. Gene Therapy 2001; 8: 1547-1554.
21. Nath S, Devi GR. Three-dimensional culture systems in cancer research: focus on tumor spheroid model [review]. Pharmacol Ther 2016; 163: 94-108.
22. Erkan EP, Strobel T, Lewandrowski G, Tannous B, Madlener S, Czech T et al. Depletion of minichromosome maintenance protein 7 inhibits glioblastoma multiforme tumor growth in vivo. Oncogene 2014; 33: 4778-4785.
23. El-Andaloussi S, Lee Y, Lakhal-Littleton S, Li J, Seow Y, Gardiner C et al. Exosome-mediated delivery of siRNA in vitro and in vivo. Nat Protoc 2012; 7: 2112-2126.